◆ 会议时间:2020年8月4-8日 推迟至2021年举办,请在下方进入2021年会议页面
◆ 会议地点:荷兰 阿姆斯特丹Amsterdam
◆ 会议改期:2021年第18届世界疼痛大会(IASP2021)
◆ 会议简介:
2020年第18届世界疼痛医学大会(IASP 2020)将于2020年8月4-8日在荷兰阿姆斯特丹举行,会议由国际疼痛研究协会(IASP)主办。IASP世界疼痛大会是世界上最大的致力于疼痛治疗与研究的多学科国际会议,每两年举办一次,会议将吸引来自世界各地的数千名专家,致力于分享疼痛研究、治疗和教育方面的最新进展,包括实验室科学、临床诊断、管理和预防等等方面;参与者包括基础科学家、研究人员、临床医生、医师、学生和受训人员等等。
国际疼痛研究协会(ISAP)成立于1973年,是疼痛医学领域领先的科学、实践和教育专业组织,目前IASP在全球133个国家拥有7900多名成员,包括科学家、临床医生、卫生保健提供者和决策者。
—领域国际医学会议网翻译整理,未经本站允许,禁止复制、转载本站任何内容。
The IASP World Congress on Pain® is the preeminent global meeting devoted to sharing new developments in pain research, treatment, and education. The congress brings together thousands of delegates from more than 100 countries across multiple disciplines. Participants include basic scientists, researchers, clinicians, physicians, students, and trainees—all of whom are devoted to improving pain relief worldwide.
Learn at plenary sessions, topical workshops, poster sessions, hands-on workshops, refresher courses, and more. Plus, access the latest tools, resources, and technologies in the Exhibit Hall. Discover, explore, and share the ever-changing advances in the study of pain at IASP’s World Congress on Pain.
摘要提交:
Call for Poster Abstracts opens on 16 December 2019.
Submissions are due by 23:59 EDT on 15 January 2020. (Convert to your local time zone).
IASP 2020注册费-All rates listed in USD
Registration Type |
Early
(By 18 March 2020) |
Regular
(19 March-15 July 2020) |
On Site
(After 15 July 2020) |
IASP Member |
$875 |
$995 |
$1,095 |
Nonmember |
$1,255 |
$1,395 |
$1,555 |
IASP Trainee Member |
$425 |
$475 |
$475 |
Nonmember Trainee |
$625 |
$675 |
$675 |
IASP Member from a Developing Country* |
$425 |
$475 |
$475 |
Nonmember from a Developing Country* |
$625 |
$675 |
$675 |
Topical Workshop Speaker
(50% off Current Member Rate) |
$438 |
$498 |
$548 |
Registration Type |
Early
(By 18 March 2020) |
Regular
(19 March-15 July 2020) |
On Site
(After 15 July 2020) |
Daily Rate |
$595 |
$595 |
$655 |
Accompanying Guest
(not in the pain field) |
$215 |
$215 |
$275 |
◆ 参会对象:
政府官员、医院管理者、科室主任、副主任、医生及从相关领域研究的专家、科研人员、医药企业等
|